Cortical tau load is associated with white matter hyperintensities
- PMID: 26419828
- PMCID: PMC4589169
- DOI: 10.1186/s40478-015-0240-0
Cortical tau load is associated with white matter hyperintensities
Abstract
Introduction: Cerebral white matter lesions (WML), visualized as white matter hyperintensities (WMH) on T2-weighted MRI, encompass structural damage and loss of integrity of the cerebral white matter (WM) and are commonly assumed to be associated with small vessel disease (SVD). However, it has been suggested that WM damage may also be the result of degenerative axonal loss that is secondary to cortical Alzheimer's disease (AD) pathologies i.e., hyperphosphorylated tau (HPτ) and amyloid-beta (Aβ). Here we investigate the influence of HPτ, Aβ and SVD on WMH severity.
Results: 36 human post-mortem right fixed cerebral hemispheres (mean age 84.4 ± 7.7 years; male: 16, female: 20) containing varying amounts of AD-pathology (AD: 23, controls: 13) underwent T2- weighted MRI with WMH assessed according to the age related white matter change scale (ARWMC). After dissection, using tissue samples from the frontal, temporal, parietal and occipital regions from the right hemisphere, we quantitatively assessed cortical HPτ and Aβ pathology burden by measuring the percentage area covered by AT8 immunoreactivity (HPτ-IR) and 4G8 immunoreactivity (Aβ-IR), and assessed the severity of WM SVD by calculating the sclerotic index (SI) of WM arteries/arterioles. HPτ-IR, Aβ-IR, and SI were compared with ARWMC scores. HPτ-IR, Aβ-IR and WM ARWMC scores were all significantly higher in AD cases compared to controls, while SI values were similar between groups. ARWMC scores correlated with HPτ-IR, Aβ-IR and SI in various regions, however, linear regression revealed that only HPτ-IR was a significant independent predictor of ARWMC scores.
Conclusions: Here we have shown that increasing cortical HPτ burden independently predicted the severity of WMH indicating its potentially important role in the pathogenesis of WM damage. Moreover, our findings suggest that in AD patients the presence of WMH may indicate cortical AD-associated pathology rather than SVD. Further studies are warranted to elucidate the pathological processes that lead to WM damage and to clarify if WMH may serve as a general biomarker for cortical AD-associated pathology.
Figures
Similar articles
-
Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.Brain Pathol. 2019 May;29(3):414-424. doi: 10.1111/bpa.12685. Epub 2019 Jan 29. Brain Pathol. 2019. PMID: 30485582 Free PMC article.
-
Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology.Acta Neuropathol. 2021 Dec;142(6):937-950. doi: 10.1007/s00401-021-02376-2. Epub 2021 Oct 4. Acta Neuropathol. 2021. PMID: 34608542 Free PMC article.
-
Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.Acta Neuropathol. 2017 Sep;134(3):459-473. doi: 10.1007/s00401-017-1738-2. Epub 2017 Jun 21. Acta Neuropathol. 2017. PMID: 28638989 Free PMC article.
-
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.J Alzheimers Dis. 2014;42 Suppl 4:S421-9. doi: 10.3233/JAD-141461. J Alzheimers Dis. 2014. PMID: 25227313 Review.
-
White Matter Hyperintensity as a Vascular Contribution to the AT(N) Framework.J Prev Alzheimers Dis. 2023;10(3):387-400. doi: 10.14283/jpad.2023.53. J Prev Alzheimers Dis. 2023. PMID: 37357280 Review.
Cited by
-
Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.Alzheimers Res Ther. 2024 Mar 7;16(1):50. doi: 10.1186/s13195-024-01417-8. Alzheimers Res Ther. 2024. PMID: 38454444 Free PMC article.
-
Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases.Int J Mol Sci. 2024 Feb 14;25(4):2268. doi: 10.3390/ijms25042268. Int J Mol Sci. 2024. PMID: 38396946 Free PMC article. Review.
-
Proteomic Changes in the Human Cerebrovasculature in Alzheimer's Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal Fluid.medRxiv [Preprint]. 2024 Jan 11:2024.01.10.24301099. doi: 10.1101/2024.01.10.24301099. medRxiv. 2024. PMID: 38260316 Free PMC article. Preprint.
-
Suspecting Non-Alzheimer's Pathologies and Mixed Pathologies: A Comparative Study Between Brain Metabolism and Tau Images.J Alzheimers Dis. 2024;97(1):421-433. doi: 10.3233/JAD-230696. J Alzheimers Dis. 2024. PMID: 38108350 Free PMC article.
-
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease.JAMA Neurol. 2023 Dec 1;80(12):1353-1363. doi: 10.1001/jamaneurol.2023.3618. JAMA Neurol. 2023. PMID: 37843849
References
-
- Bosch B, Arenaza-Urquijo EM, Rami L, Sala-Llonch R, Junque C, Sole-Padulles C, Pena-Gomez C, Bargallo N, Molinuevo JL, Bartres-Faz D. Multiple DTI index analysis in normal aging, amnestic MCI and AD. Relationship with neuropsychological performance. Neurobiol Aging. 2012;33:61–74. doi: 10.1016/j.neurobiolaging.2010.02.004. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
